Emerging therapies in the medical treatment of uterine fibroids

被引：0

作者：

Goitia, Mikel ^{[1
]}

Estadella, Josep ^{[2
]}

机构：

[1] Hosp Univ Cruces, Serv Ginecol & Obstet, Baracaldo, Bizkaia, Spain

[2] Hosp De La Santa Creu & St Pau, Serv Ginecol, Barcelona, Spain

来源：

MEDICINA CLINICA | 2023年 / 161卷

关键词：

PROGESTERONE-RECEPTOR MODULATORS; ADD-BACK THERAPY; ULIPRISTAL ACETATE; ANTAGONIST LINZAGOLIX; WOMEN; EFFICACY; SAFETY; ELAGOLIX; PLACEBO; VILAPRISAN;

D O I：

10.1016/j.medcli.2023.06.034

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S32 / S37

页数：6

共 42 条

[1] Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy [J].

Al-Hendy, Ayman ;

Lukes, Andrea S. ;

Poindexter, Alfred N., III ;

Venturella, Roberta ;

Villarroel, Claudio ;

Critchley, Hilary O. D. ;

Li, Yulan ;

McKain, Laura ;

Ferreira, Juan C. Arjona ;

Langenberg, Andria G. M. ;

Wagman, Rachel B. ;

Stewart, Elizabeth A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (07) :630-642

[2]

Al-Hendy A, 2020, FERTIL STERIL, V114, pE1

[3] Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study [J].

Archer, David F. ;

Stewart, Elizabeth A. ;

Jain, Rita I. ;

Feldman, Robert A. ;

Lukes, Andrea S. ;

North, Janine D. ;

Soliman, Ahmed M. ;

Gao, Jingjing ;

Ng, Juki W. ;

Chwalisz, Kristof .

FERTILITY AND STERILITY, 2017, 108 (01) :152-+

[4] The impact of uterine leiomyomas: a national survey of affected women [J].

Borah, Bijan J. ;

Nicholson, Wanda K. ;

Bradley, Linda ;

Stewart, Elizabeth A. .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2013, 209 (04)

[5] Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety [J].

Bouchard, Philippe ;

Chabbert-Buffet, Nathalie ;

Fauser, Bart C. J. M. .

FERTILITY AND STERILITY, 2011, 96 (05) :1175-1189

[6] Vilaprisan in women with uterine fibroids: the randomized phase 2b ASTEROID 1 study [J].

Bradley, Linda D. ;

Singh, Sukhbir S. ;

Simon, James ;

Gemzell-Danielsson, Kristina ;

Petersdorf, Kathrin ;

Groettrup-Wolfers, Esther ;

Ren, Xiaowei ;

Zvolanek, Michal ;

Seitz, Christian .

FERTILITY AND STERILITY, 2019, 111 (02) :240-248

[7] The medical management of abnormal uterine bleeding in reproductive-aged women [J].

Bradley, Linda D. ;

Gueye, Ndeye-Aicha .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 214 (01) :31-44

[8] Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas A Randomized Controlled Trial [J].

Carr, Bruce R. ;

Stewart, Elizabeth A. ;

Archer, David F. ;

Al-Hendy, Ayman ;

Bradley, Linda ;

Watts, Nelson B. ;

Diamond, Michael P. ;

Gao, Jingjing ;

Owens, Charlotte D. ;

Chwalisz, Kristof ;

Duan, W. Rachel ;

Soliman, Ahmed M. ;

Dufek, Matthew B. ;

Simon, James A. .

OBSTETRICS AND GYNECOLOGY, 2018, 132 (05) :1252-1264

[9] Linzagolix: a new GnRH-antagonist under investigation for the treatment of endometriosis and uterine myomas [J].

Dababou, Susan ;

Garzon, Simone ;

Lagana, Antonio Simone ;

Ferrero, Simone ;

Evangelisti, Giulio ;

Noventa, Marco ;

D'Alterio, Maurizio Nicola ;

Palomba, Stefano ;

Uccella, Stefano ;

Franchi, Massimo ;

Barra, Fabio .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2021, 30 (09) :903-911

[10] A benefit-risk assessment of medical treatment for uterine leiomyomas [J].

De Leo, V ;

Morgante, G ;

La Marca, A ;

Musacchio, MC ;

Sorace, M ;

Cavicchioli, C ;

Petraglia, F .

DRUG SAFETY, 2002, 25 (11) :759-779

← 1 2 3 4 5 →